PATENT CLAIM ANALYSIS

Application Number: 16090317
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "161000"]

Abstract:
Methods of treating and preventing conditions of a nasal or paranasal mucous membrane are described. The methods include administering a pharmaceutical composition including a nicotinic acetylcholine receptor (nAChR) agonist, such as (S)-(1-methyl-2-pyrrolidinyl)-pyridine, or a pharmaceutically acceptable salt, analog, precursor or derivative thereof. The methods can be used to treat a wide variety of conditions of the nasal or paranasal mucous membrane, such as nasal congestion and nose bleeds.

Claim (Index 4):
The method of  claim 1 , wherein the condition of the nasal or paranasal mucous membrane is selected from the group consisting of nasal congestion, rhinitis, allergic rhinitis, acute rhinitis, atrophic rhinitis, vasomotor rhinitis, chronic or recurrent sinusitis, an inflammation, a chronic inflammatory disease, an acute inflammatory disease, hemorrhages, minor bleeding, a chronic degenerative disease, an acute degenerative disease, edema of the mucous membranes, and edema of one or more turbinates.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 97.0
- Lexical Diversity: 1.57407
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14470197', '12675257', '15004807', '10912578', '13838959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8148098899941937
- 35 USC 102 Novelty (BERT): 0.4928055874394376
- Combined Prediction Score: 0.7826094597387181
- Mean Citation Score: 236.049792
- Max Citation Score: 266.14062
- Similarity Product: 221.85914740390783

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test